The study highlighted a mechanism by which PCSK9 may influence SLE progression, revealing elevated oxLDL levels in SLE patients and its role in stimulating the activation and maturation of DCs as PCSK9-dependent antigen-presenting cells (APCs), offering insights into PCSK9’s role in SLE progression.288. This evidence concerns the gene PCSK9 and systemic lupus erythematosus.